{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:19:50Z","timestamp":1790777990195,"version":"4.1.0"},"reference-count":127,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1053\/j.ackd.2013.10.001","type":"journal-article","created":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T09:53:08Z","timestamp":1387533188000},"page":"81-90","source":"Crossref","is-referenced-by-count":164,"title":["Hereditary Kidney Cancer Syndromes"],"prefix":"10.1053","volume":"21","author":[{"given":"Naomi B.","family":"Haas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Nathanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.ackd.2013.10.001_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF01994821","article-title":"Uber eine sehr seltene Erkanung der netzhaut","volume":"59","author":"Von Hippel","year":"1904","journal-title":"Graefes Arch Clin Exp Opthalmol"},{"issue":"suppl","key":"10.1053\/j.ackd.2013.10.001_bib2","first-page":"1","article-title":"Studien ber kleinbirncysten bau: pathogenese und beziehungen zur angiomatosis retinae","volume":"1","author":"Lindau","year":"1926","journal-title":"Acta Radiol Microbiol Scandinavica"},{"issue":"4","key":"10.1053\/j.ackd.2013.10.001_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/hmg\/3.4.595","article-title":"Detailed mapping of germline deletions of the von Hippel-Lindau disease tumour suppressor gene","volume":"3","author":"Richards","year":"1994","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1053\/j.ackd.2013.10.001_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/jmg.30.2.104","article-title":"Detailed genetic mapping of the von Hippel-Lindau disease tumour suppressor gene","volume":"30","author":"Richards","year":"1993","journal-title":"J Med Genet"},{"issue":"7","key":"10.1053\/j.ackd.2013.10.001_bib5","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/hmg\/2.7.879","article-title":"Mapping the Von Hippel-Lindau disease tumour suppressor gene: identification of germline deletions by pulsed field gel electrophoresis","volume":"2","author":"Richards","year":"1993","journal-title":"Hum Mol Genet"},{"issue":"5112","key":"10.1053\/j.ackd.2013.10.001_bib6","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel-Lindau disease tumor suppressor gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"issue":"4","key":"10.1053\/j.ackd.2013.10.001_bib7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/0888-7543(91)90185-H","article-title":"Mapping of the von Hippel-Lindau disease locus to a small region of chromosome 3p by genetic linkage analysis","volume":"10","author":"Maher","year":"1991","journal-title":"Genomics"},{"issue":"4","key":"10.1053\/j.ackd.2013.10.001_bib8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/jmg.33.4.328","article-title":"Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations","volume":"33","author":"Maher","year":"1996","journal-title":"J Med Genet"},{"issue":"2","key":"10.1053\/j.ackd.2013.10.001_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/humu.20385","article-title":"Genotype-phenotype correlations in von Hippel-Lindau disease","volume":"28","author":"Ong","year":"2007","journal-title":"Hum Mutat"},{"issue":"4","key":"10.1053\/j.ackd.2013.10.001_bib10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3","article-title":"Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan","volume":"8","author":"Zbar","year":"1996","journal-title":"Hum Mutat"},{"issue":"4","key":"10.1053\/j.ackd.2013.10.001_bib11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s004390000265","article-title":"Genotype-phenotype correlations in families with deletions in the von Hippel-Lindau (VHL) gene","volume":"106","author":"Hes","year":"2000","journal-title":"Hum Genet"},{"issue":"1","key":"10.1053\/j.ackd.2013.10.001_bib12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/humu.1380050109","article-title":"Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype","volume":"5","author":"Chen","year":"1995","journal-title":"Hum Mutat"},{"issue":"5","key":"10.1053\/j.ackd.2013.10.001_bib13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/BF00223868","article-title":"Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect","volume":"95","author":"Brauch","year":"1995","journal-title":"Hum Genet"},{"issue":"7","key":"10.1053\/j.ackd.2013.10.001_bib14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/jmg.28.7.443","article-title":"Von Hippel-Lindau disease: a genetic study","volume":"28","author":"Maher","year":"1991","journal-title":"J Med Genet"},{"issue":"283","key":"10.1053\/j.ackd.2013.10.001_bib15","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/qjmed\/77.2.1151","article-title":"Clinical features and natural history of von Hippel-Lindau disease","volume":"77","author":"Maher","year":"1990","journal-title":"Q J Med"},{"issue":"1","key":"10.1053\/j.ackd.2013.10.001_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00218913","article-title":"Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours","volume":"93","author":"Crossey","year":"1994","journal-title":"Hum Genet"},{"issue":"1","key":"10.1053\/j.ackd.2013.10.001_bib17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/(SICI)1098-1004(200001)15:1<114::AID-HUMU20>3.0.CO;2-7","article-title":"Somatic mosaicism in von Hippel-Lindau Disease","volume":"15","author":"Murgia","year":"2000","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1053\/j.ackd.2013.10.001_bib18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1086\/302726","article-title":"Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents","volume":"66","author":"Sgambati","year":"2000","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1053\/j.ackd.2013.10.001_bib19","first-page":"951","article-title":"Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas","volume":"151","author":"Vortmeyer","year":"1997","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1053\/j.ackd.2013.10.001_bib20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/ajcp\/107.4.459","article-title":"Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas","volume":"107","author":"Tse","year":"1997","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1053\/j.ackd.2013.10.001_bib21","first-page":"2089","article-title":"Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients","volume":"149","author":"Lubensky","year":"1996","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1053\/j.ackd.2013.10.001_bib22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1535-6108(02)00071-5","article-title":"HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron","volume":"1","author":"Mandriota","year":"2002","journal-title":"Cancer Cell"},{"issue":"5229","key":"10.1053\/j.ackd.2013.10.001_bib23","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.7660130","article-title":"Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C","volume":"269","author":"Kibel","year":"1995","journal-title":"Science"},{"issue":"20","key":"10.1053\/j.ackd.2013.10.001_bib24","first-page":"4544","article-title":"Cellular proteins that bind the von Hippel-Lindau disease gene product: mapping of binding domains and the effect of missense mutations","volume":"55","author":"Kishida","year":"1995","journal-title":"Cancer Res"},{"issue":"5413","key":"10.1053\/j.ackd.2013.10.001_bib25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1126\/science.284.5413.455","article-title":"Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function","volume":"284","author":"Stebbins","year":"1999","journal-title":"Science"},{"issue":"11","key":"10.1053\/j.ackd.2013.10.001_bib26","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1172\/JCI8161","article-title":"Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein","volume":"104","author":"Ohh","year":"1999","journal-title":"J Clin Invest"},{"issue":"33","key":"10.1053\/j.ackd.2013.10.001_bib27","doi-asserted-by":"crossref","first-page":"25733","DOI":"10.1074\/jbc.M002740200","article-title":"Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor\u00a0suppressor protein","volume":"275","author":"Cockman","year":"2000","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1053\/j.ackd.2013.10.001_bib28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0959-437X(02)00010-2","article-title":"The von Hippel-Lindau tumor suppressor protein: new insights into oxygen sensing and cancer","volume":"13","author":"Kim","year":"2003","journal-title":"Curr Opin Genet Dev"},{"issue":"4","key":"10.1053\/j.ackd.2013.10.001_bib29","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1158\/0008-5472.CAN-05-3074","article-title":"Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer","volume":"66","author":"Banks","year":"2006","journal-title":"Cancer Res"},{"issue":"1","key":"10.1053\/j.ackd.2013.10.001_bib30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1158\/0008-5472.CAN-11-1698","article-title":"Integrative genomic analyses of sporadic clear cell renal cell carcinoma define disease subtypes and potential new therapeutic targets","volume":"72","author":"Dondeti","year":"2012","journal-title":"Cancer Res"},{"issue":"6","key":"10.1053\/j.ackd.2013.10.001_bib31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ccr.2008.10.016","article-title":"HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma","volume":"14","author":"Gordan","year":"2008","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1053\/j.ackd.2013.10.001_bib32","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1046\/j.1365-2796.1998.00334.x","article-title":"Molecular genetic analysis of von Hippel-Lindau disease","volume":"243","author":"Richards","year":"1998","journal-title":"J Intern Med"},{"issue":"15","key":"10.1053\/j.ackd.2013.10.001_bib33","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1128\/MCB.00282-07","article-title":"Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations","volume":"27","author":"Li","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"10","key":"10.1053\/j.ackd.2013.10.001_bib34","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/hmg\/10.10.1029","article-title":"Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease","volume":"10","author":"Clifford","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1053\/j.ackd.2013.10.001_bib35","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/sj.onc.1209062","article-title":"Renal cell carcinoma risk in type 2 von Hippel-Lindau disease correlates with defects in pVHL stability and HIF-1alpha interactions","volume":"25","author":"Knauth","year":"2006","journal-title":"Oncogene"},{"issue":"12","key":"10.1053\/j.ackd.2013.10.001_bib36","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1097\/00007890-199712270-00017","article-title":"Results of renal transplantation in patients with renal cell carcinoma and von Hippel-Lindau disease","volume":"64","author":"Goldfarb","year":"1997","journal-title":"Transplantation"},{"issue":"5","key":"10.1053\/j.ackd.2013.10.001_bib37","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0022-5347(05)68930-6","article-title":"Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery","volume":"161","author":"Walther","year":"1999","journal-title":"J Urol"},{"issue":"1","key":"10.1053\/j.ackd.2013.10.001_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/01.ju.0000132127.79974.3f","article-title":"The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease","volume":"172","author":"Duffey","year":"2004","journal-title":"J Urol"},{"issue":"1","key":"10.1053\/j.ackd.2013.10.001_bib39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2007.13.3223","article-title":"Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma","volume":"26","author":"Choueiri","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.ackd.2013.10.001_bib40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1479-5876-8-8","article-title":"A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic renal cell carcinoma","volume":"8","author":"Rahma","year":"2010","journal-title":"J Transl Med"},{"issue":"20","key":"10.1053\/j.ackd.2013.10.001_bib41","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1158\/1078-0432.CCR-04-0516","article-title":"The in\u00a0vitro and\u00a0in\u00a0vivo effects of re-expressing methylated von Hippel-Lindau tumor suppressor gene in clear cell renal carcinoma with\u00a05-aza-2'-deoxycytidine","volume":"10","author":"Alleman","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"3 Pt 2","key":"10.1053\/j.ackd.2013.10.001_bib42","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0022-5347(01)67601-8","article-title":"Hereditary papillary renal cell carcinoma: clinical studies in 10 families","volume":"153","author":"Zbar","year":"1995","journal-title":"J Urol"},{"issue":"3","key":"10.1053\/j.ackd.2013.10.001_bib43","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-5347(17)35015-2","article-title":"Hereditary papillary renal cell carcinoma","volume":"151","author":"Zbar","year":"1994","journal-title":"J Urol"},{"issue":"1","key":"10.1053\/j.ackd.2013.10.001_bib44","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng0597-68","article-title":"Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas","volume":"16","author":"Schmidt","year":"1997","journal-title":"Nat Genet"},{"issue":"14","key":"10.1053\/j.ackd.2013.10.001_bib45","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1038\/sj.onc.1202547","article-title":"Novel mutations of the MET proto-oncogene in papillary renal carcinomas","volume":"18","author":"Schmidt","year":"1999","journal-title":"Oncogene"},{"issue":"2","key":"10.1053\/j.ackd.2013.10.001_bib46","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9440(10)65147-4","article-title":"Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype","volume":"155","author":"Lubensky","year":"1999","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1053\/j.ackd.2013.10.001_bib47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/109065701753145547","article-title":"Papillary renal cell carcinoma: analysis of germline mutations in the MET proto-oncogene in a clinic-based population","volume":"5","author":"Lindor","year":"2001","journal-title":"Genet Test"},{"issue":"8","key":"10.1053\/j.ackd.2013.10.001_bib48","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2174\/1566524043359674","article-title":"Hereditary papillary renal carcinoma type I","volume":"4","author":"Dharmawardana","year":"2004","journal-title":"Curr Mol Med"},{"issue":"1","key":"10.1053\/j.ackd.2013.10.001_bib49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/376435","article-title":"Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America","volume":"73","author":"Toro","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"11","key":"10.1053\/j.ackd.2013.10.001_bib50","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/hmg\/ddg148","article-title":"Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency","volume":"12","author":"Alam","year":"2003","journal-title":"Hum Mol Genet"},{"issue":"10","key":"10.1053\/j.ackd.2013.10.001_bib51","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","article-title":"The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome","volume":"31","author":"Merino","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1053\/j.ackd.2013.10.001_bib52","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.juro.2007.01.155","article-title":"Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer","volume":"177","author":"Grubb","year":"2007","journal-title":"J Urol"},{"issue":"1","key":"10.1053\/j.ackd.2013.10.001_bib53","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jmg.2005.033506","article-title":"Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer","volume":"43","author":"Wei","year":"2006","journal-title":"J Med Genet"},{"issue":"1","key":"10.1053\/j.ackd.2013.10.001_bib54","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1399-0004.2010.01486.x","article-title":"Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis","volume":"79","author":"Smit","year":"2011","journal-title":"Clin Genet"},{"key":"10.1053\/j.ackd.2013.10.001_bib55","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2350-9-20","article-title":"The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency","volume":"9","author":"Bayley","year":"2008","journal-title":"BMC Med Genet"},{"issue":"9","key":"10.1053\/j.ackd.2013.10.001_bib56","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/jmg.2006.041087","article-title":"Fumarate hydratase enzyme activity in lymphoblastoid cells and fibroblasts of individuals in families with hereditary leiomyomatosis and renal cell cancer","volume":"43","author":"Pithukpakorn","year":"2006","journal-title":"J Med Genet"},{"issue":"4","key":"10.1053\/j.ackd.2013.10.001_bib57","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/jmg.2010.085068","article-title":"Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma","volume":"48","author":"Gardie","year":"2011","journal-title":"J Med Genet"},{"issue":"2","key":"10.1053\/j.ackd.2013.10.001_bib58","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10689-009-9312-2","article-title":"No evidence for a genetic modifier for renal cell cancer risk in HLRCC syndrome","volume":"9","author":"Vahteristo","year":"2010","journal-title":"Fam Cancer"},{"issue":"3 Pt 1","key":"10.1053\/j.ackd.2013.10.001_bib59","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1212\/WNL.40.3_Part_1.495","article-title":"Fumarase deficiency is an autosomal recessive encephalopathy affecting both the mitochondrial and the cytosolic enzymes","volume":"40","author":"Gellera","year":"1990","journal-title":"Neurology"},{"issue":"6","key":"10.1053\/j.ackd.2013.10.001_bib60","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1172\/JCI117261","article-title":"Mutation of the fumarase gene in two siblings with progressive encephalopathy and fumarase deficiency","volume":"93","author":"Bourgeron","year":"1994","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1053\/j.ackd.2013.10.001_bib61","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/mgme.1998.2684","article-title":"Molecular analysis and prenatal diagnosis of human fumarase deficiency","volume":"63","author":"Coughlin","year":"1998","journal-title":"Mol Genet Metab"},{"issue":"4","key":"10.1053\/j.ackd.2013.10.001_bib62","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1023\/A:1005379330187","article-title":"Fumarate hydratase deficiency","volume":"21","author":"Bonioli","year":"1998","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"10.1053\/j.ackd.2013.10.001_bib63","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10545-006-0321-0","article-title":"Fumaric aciduria: mild phenotype in a 8-year-old girl with novel mutations","volume":"29","author":"Maradin","year":"2006","journal-title":"J Inherit Metab Dis"},{"issue":"9","key":"10.1053\/j.ackd.2013.10.001_bib64","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/humu.21534","article-title":"Clinical and biochemical heterogeneity associated with fumarase deficiency","volume":"32","author":"Ottolenghi","year":"2011","journal-title":"Hum Mutat"},{"issue":"13","key":"10.1053\/j.ackd.2013.10.001_bib65","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1158\/1078-0432.CCR-13-0304","article-title":"Molecular pathways: fumarate hydratase-deficient kidney cancer\u2013targeting the warburg effect in cancer","volume":"19","author":"Linehan","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1053\/j.ackd.2013.10.001_bib66","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ccr.2011.09.006","article-title":"Renal cyst formation in Fh1-deficient mice is independent of the Hif\/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling","volume":"20","author":"Adam","year":"2011","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1053\/j.ackd.2013.10.001_bib67","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ccr.2011.08.024","article-title":"An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma","volume":"20","author":"Ooi","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1053\/j.ackd.2013.10.001_bib68","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-60761-738-9_3","article-title":"Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents","volume":"647","author":"Giudice","year":"2010","journal-title":"Methods Mol Biol"},{"issue":"3","key":"10.1053\/j.ackd.2013.10.001_bib69","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ccr.2011.07.018","article-title":"The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels","volume":"20","author":"Tong","year":"2011","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1053\/j.ackd.2013.10.001_bib70","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.2932","article-title":"Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status","volume":"225","author":"Bardella","year":"2011","journal-title":"J Pathol"},{"issue":"1","key":"10.1053\/j.ackd.2013.10.001_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.2950","article-title":"Seeing the smoking gun: a sensitive and specific method to visualize loss of the tumour suppressor, fumarate hydratase, in human tissues","volume":"225","author":"Maxwell","year":"2011","journal-title":"J Pathol"},{"issue":"7","key":"10.1053\/j.ackd.2013.10.001_bib72","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/gcc.20663","article-title":"Array comparative genomic hybridization identifies a distinct DNA copy number profile in renal cell cancer associated with hereditary leiomyomatosis and renal cell cancer","volume":"48","author":"Koski","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"10.1053\/j.ackd.2013.10.001_bib73","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1073\/pnas.051633798","article-title":"Inherited susceptibility to uterine leiomyomas and renal cell cancer","volume":"98","author":"Launonen","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1053\/j.ackd.2013.10.001_bib74","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in\u00a0FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat Genet"},{"issue":"12","key":"10.1053\/j.ackd.2013.10.001_bib75","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1001\/archdermatol.2008.517","article-title":"Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer","volume":"144","author":"Stewart","year":"2008","journal-title":"Arch Dermatol"},{"issue":"8","key":"10.1053\/j.ackd.2013.10.001_bib76","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/PAS.0b013e318223ca01","article-title":"Morphologic features of uterine leiomyomas associated with hereditary leiomyomatosis and renal cell carcinoma syndrome: a case report","volume":"35","author":"Garg","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1053\/j.ackd.2013.10.001_bib77","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archderm.141.2.199","article-title":"Clinical features of multiple cutaneous and uterine leiomyomatosis: an underdiagnosed tumor syndrome","volume":"141","author":"Alam","year":"2005","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1053\/j.ackd.2013.10.001_bib78","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2133.2008.09000.x","article-title":"Wilms tumour as a possible early manifestation of hereditary leiomyomatosis and renal cell cancer?","volume":"160","author":"Badeloe","year":"2009","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1053\/j.ackd.2013.10.001_bib79","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1210\/jc.2006-0183","article-title":"Adult Leydig cell tumors of the testis caused by germline fumarate hydratase mutations","volume":"91","author":"Carvajal-Carmona","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1053\/j.ackd.2013.10.001_bib80","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s10227-005-0114-3","article-title":"Multiple cutaneous and uterine leiomyomas associated with gastric GIST","volume":"9","author":"Lamba","year":"2005","journal-title":"J Cutan Med Surg"},{"issue":"6","key":"10.1053\/j.ackd.2013.10.001_bib81","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1210\/jc.2004-2377","article-title":"Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical Cushing syndrome: a clinical and molecular genetic investigation","volume":"90","author":"Matyakhina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"13","key":"10.1053\/j.ackd.2013.10.001_bib82","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1158\/1078-0432.CCR-10-0574","article-title":"A phase I study of foretinib, a multi-targeted inhibitor of c-Met and vascular endothelial growth factor receptor 2","volume":"16","author":"Eder","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1053\/j.ackd.2013.10.001_bib83","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/JCO.2012.43.3383","article-title":"Phase II and\u00a0biomarker study of the dual MET\/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma","volume":"31","author":"Choueiri","year":"2013","journal-title":"J Clin Oncol"},{"issue":"34","key":"10.1053\/j.ackd.2013.10.001_bib84","doi-asserted-by":"crossref","first-page":"5788","DOI":"10.1200\/JCO.2008.18.8821","article-title":"Phase II study of erlotinib in patients with locally advanced or metastatic papillary histology renal cell cancer: SWOG S0317","volume":"27","author":"Gordon","year":"2009","journal-title":"J Clin Oncol"},{"issue":"37","key":"10.1053\/j.ackd.2013.10.001_bib85","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1038\/sj.onc.1204703","article-title":"Birt-Hogg-Dube syndrome: mapping of a novel hereditary neoplasia gene to chromosome 17p12-q11.2","volume":"20","author":"Khoo","year":"2001","journal-title":"Oncogene"},{"issue":"4","key":"10.1053\/j.ackd.2013.10.001_bib86","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1086\/323744","article-title":"Birt-Hogg-Dube syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2","volume":"69","author":"Schmidt","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1053\/j.ackd.2013.10.001_bib87","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1535-6108(02)00104-6","article-title":"Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome","volume":"2","author":"Nickerson","year":"2002","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1053\/j.ackd.2013.10.001_bib88","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/gcc.20872","article-title":"Identification of intragenic deletions and duplication in the FLCN gene in Birt-Hogg-Dube syndrome","volume":"50","author":"Benhammou","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"issue":"21","key":"10.1053\/j.ackd.2013.10.001_bib89","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1093\/hmg\/ddt288","article-title":"Birt-Hogg-Dube syndrome is a novel ciliopathy","volume":"22","author":"Luijten","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"11","key":"10.1053\/j.ackd.2013.10.001_bib90","doi-asserted-by":"crossref","first-page":"e47842","DOI":"10.1371\/journal.pone.0047842","article-title":"Folliculin, the product of the Birt-Hogg-Dube tumor suppressor gene, interacts with the adherens junction protein p0071 to regulate cell-cell adhesion","volume":"7","author":"Medvetz","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1053\/j.ackd.2013.10.001_bib91","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/hmg\/dds428","article-title":"The Birt-Hogg-Dube tumor suppressor Folliculin negatively regulates ribosomal RNA synthesis","volume":"22","author":"Gaur","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1053\/j.ackd.2013.10.001_bib92","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/01.ju.0000154629.45832.30","article-title":"Evaluation and management of renal tumors in the Birt-Hogg-Dube syndrome","volume":"173","author":"Pavlovich","year":"2005","journal-title":"J Urol"},{"issue":"15","key":"10.1053\/j.ackd.2013.10.001_bib93","first-page":"4583","article-title":"Inactivation of BHD in sporadic renal tumors","volume":"63","author":"Khoo","year":"2003","journal-title":"Cancer Res"},{"issue":"11","key":"10.1053\/j.ackd.2013.10.001_bib94","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/jmg.40.11.820","article-title":"Analysis of the Birt-Hogg-Dube (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer","volume":"40","author":"da Silva","year":"2003","journal-title":"J Med Genet"},{"issue":"12","key":"10.1053\/j.ackd.2013.10.001_bib95","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S1470-2045(09)70188-3","article-title":"Birt-Hogg-Dube syndrome: diagnosis and management","volume":"10","author":"Menko","year":"2009","journal-title":"Lancet Oncol"},{"issue":"suppl 10","key":"10.1053\/j.ackd.2013.10.001_bib96","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/cncr.24230","article-title":"Hereditary kidney cancer: unique opportunity for disease-based therapy","volume":"115","author":"Linehan","year":"2009","journal-title":"Cancer"},{"issue":"7","key":"10.1053\/j.ackd.2013.10.001_bib97","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.2323","article-title":"BAP1 loss defines a new class of renal cell carcinoma","volume":"44","author":"Pena-Llopis","year":"2012","journal-title":"Nat Genet"},{"issue":"2","key":"10.1053\/j.ackd.2013.10.001_bib98","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1470-2045(12)70584-3","article-title":"Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation","volume":"14","author":"Kapur","year":"2013","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1053\/j.ackd.2013.10.001_bib99","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1158\/1541-7786.MCR-13-0111","article-title":"A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma","volume":"11","author":"Farley","year":"2013","journal-title":"Mol Cancer Res"},{"key":"10.1053\/j.ackd.2013.10.001_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajhg.2013.04.012","article-title":"Germline BAP1 mutations predispose to renal cell carcinomas","author":"Popova","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1053\/j.ackd.2013.10.001_bib101","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0165-4608(01)00585-4","article-title":"Cytogenetic and molecular analysis of early stage renal cell carcinomas in a family with a translocation (2;3) (q35;q21)","volume":"134","author":"Bodmer","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"issue":"8","key":"10.1053\/j.ackd.2013.10.001_bib102","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2174\/1566524043359593","article-title":"Chromosome 3 translocations and familial renal cell cancer","volume":"4","author":"Bonne","year":"2004","journal-title":"Curr Mol Med"},{"issue":"1","key":"10.1053\/j.ackd.2013.10.001_bib103","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/gcc.1114","article-title":"Molecular analysis of a familial case of renal cell cancer and a t(3;6) (q12;q15)","volume":"31","author":"Eleveld","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"10.1053\/j.ackd.2013.10.001_bib104","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/gcc.20403","article-title":"Characterization of a 3;6 translocation associated with renal cell carcinoma","volume":"46","author":"Foster","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"10.1053\/j.ackd.2013.10.001_bib105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/jmg.38.3.165","article-title":"Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma","volume":"38","author":"Kanayama","year":"2001","journal-title":"J Med Genet"},{"issue":"2","key":"10.1053\/j.ackd.2013.10.001_bib106","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1523-1755.1998.00762.x","article-title":"A familial case of renal cell carcinoma and a t(2;3) chromosome translocation","volume":"53","author":"Koolen","year":"1998","journal-title":"Kidney Int"},{"issue":"7456","key":"10.1053\/j.ackd.2013.10.001_bib107","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1053\/j.ackd.2013.10.001_bib108","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ng0597-64","article-title":"Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome","volume":"16","author":"Liaw","year":"1997","journal-title":"Nat Genet"},{"issue":"5","key":"10.1053\/j.ackd.2013.10.001_bib109","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/j.seminoncol.2007.07.009","article-title":"Cowden syndrome","volume":"34","author":"Gustafson","year":"2007","journal-title":"Semin Oncol"},{"issue":"1","key":"10.1053\/j.ackd.2013.10.001_bib110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrc2037","article-title":"Cancer phenomics: RET and PTEN as illustrative models","volume":"7","author":"Zbuk","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1053\/j.ackd.2013.10.001_bib111","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/301639","article-title":"Inherited mutations in PTEN that are associated with breast cancer, Cowden disease, and juvenile polyposis","volume":"61","author":"Lynch","year":"1997","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1053\/j.ackd.2013.10.001_bib112","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","article-title":"Lifetime cancer risks in individuals with germline PTEN mutations","volume":"18","author":"Tan","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1053\/j.ackd.2013.10.001_bib113","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1034>3.0.CO;2-S","article-title":"PTEN\/MMAC1\/TEP1 mutations in human primary renal-cell carcinomas and renal carcinoma cell lines","volume":"91","author":"Kondo","year":"2001","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1053\/j.ackd.2013.10.001_bib114","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","article-title":"SDH mutations establish a hypermethylator phenotype in paraganglioma","volume":"23","author":"Letouze","year":"2013","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1053\/j.ackd.2013.10.001_bib115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/321282","article-title":"Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma","volume":"69","author":"Astuti","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"10","key":"10.1053\/j.ackd.2013.10.001_bib116","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1210\/jc.2007-0709","article-title":"Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas","volume":"92","author":"Amar","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"10.1053\/j.ackd.2013.10.001_bib117","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/djn254","article-title":"Germline SDHB mutations and familial renal cell carcinoma","volume":"100","author":"Ricketts","year":"2008","journal-title":"J Nat Cancer Inst"},{"issue":"1","key":"10.1053\/j.ackd.2013.10.001_bib118","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1086\/381054","article-title":"Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma","volume":"74","author":"Vanharanta","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"7","key":"10.1053\/j.ackd.2013.10.001_bib119","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/jcp.2003.011767","article-title":"Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinoma","volume":"57","author":"Morris","year":"2004","journal-title":"J Clin Pathol"},{"issue":"6","key":"10.1053\/j.ackd.2013.10.001_bib120","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.juro.2012.08.030","article-title":"Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer","volume":"188","author":"Ricketts","year":"2012","journal-title":"J Urol"},{"issue":"13","key":"10.1053\/j.ackd.2013.10.001_bib121","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1053\/j.ackd.2013.10.001_bib122","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","year":"1993","journal-title":"Cell"},{"issue":"3-4","key":"10.1053\/j.ackd.2013.10.001_bib123","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00439-006-0308-9","article-title":"Identification of 54 large deletions\/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations","volume":"121","author":"Kozlowski","year":"2007","journal-title":"Hum Genet"},{"issue":"5327","key":"10.1053\/j.ackd.2013.10.001_bib124","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"van Slegtenhorst","year":"1997","journal-title":"Science"},{"issue":"1","key":"10.1053\/j.ackd.2013.10.001_bib125","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/316951","article-title":"Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs","volume":"68","author":"Dabora","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1053\/j.ackd.2013.10.001_bib126","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1159\/000320891","article-title":"Tuberous sclerosis complex renal disease","volume":"118","author":"Dixon","year":"2011","journal-title":"Nephron Exp Nephrol"},{"issue":"9869","key":"10.1053\/j.ackd.2013.10.001_bib127","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or\u00a0sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559513001444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559513001444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T01:42:15Z","timestamp":1564969335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559513001444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":127,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1548559513001444"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2013.10.001","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}